Macrogenics (MGNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,660 | -3,366 | 8,362 | 10,467 | 7,866 |
| Depreciation Amortization | 518 | 252 | 960 | 723 | 487 |
| Accounts receivable | -2,107 | -276 | N/A | -2,713 | -2,405 |
| Accounts payable and accrued liabilities | -1,620 | -945 | N/A | -5,444 | -6,090 |
| Other Working Capital | -10,982 | -910 | -16,591 | -36,099 | -26,731 |
| Other Operating Activity | 4,056 | 1,396 | 687 | 8,786 | 8,915 |
| Operating Cash Flow | $-13,795 | $-3,849 | $-6,582 | $-24,282 | $-17,959 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -876 | -425 | -940 | -530 | -245 |
| Investing Cash Flow | $-876 | $-425 | $-940 | $-530 | $-245 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 709 | 57 | N/A | 44 | 35 |
| Other Financing Activity | 0 | 0 | 47 | 0 | 0 |
| Financing Cash Flow | $709 | $57 | $47 | $44 | $35 |
| Beginning Cash Position | 47,743 | 47,743 | 55,218 | 55,218 | 55,218 |
| End Cash Position | 33,781 | 43,526 | 47,743 | 30,451 | 37,049 |
| Net Cash Flow | $-13,962 | $-4,217 | $-7,475 | $-24,767 | $-18,169 |
| Free Cash Flow | |||||
| Operating Cash Flow | -13,795 | -3,849 | -6,582 | -24,282 | -17,959 |
| Capital Expenditure | -876 | -425 | N/A | -530 | -245 |
| Free Cash Flow | -14,671 | -4,274 | -6,582 | -24,812 | -18,204 |